Maldemar

Name: Maldemar

Maldemar Overdose

If you take too much scopolamine, call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away.

What is the most important information I should know about Maldemar (scopolamine)?

You should not use scopolamine if you have narrow-angle glaucoma, a blockage in your intestines, a severe breathing disorder, or if you are unable to urinate.

What should I discuss with my healthcare provider before taking Maldemar (scopolamine)?

You should not use this medicine if you are allergic to scopolamine or similar medications such as methscopolamine or hyoscyamine, or if you have:

  • narrow-angle glaucoma;

  • a blockage in your intestines;

  • a severe breathing disorder; or

  • if you are unable to urinate.

To make sure scopolamine is safe for you, tell your doctor if you have:

  • glaucoma;

  • an enlarged prostate, bladder obstruction, or urination problems;

  • problems with your esophagus, stomach, or intestines;

  • kidney disease;

  • liver disease;

  • heart disease, high blood pressure;

  • coronary artery disease (hardened arteries);

  • overactive thyroid;

  • myasthenia gravis;

  • asthma or other breathing problems;

  • a drug allergy; or

  • a history of head injury or brain tumor.

It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It is not known whether scopolamine passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Scopolamine is not approved for use by anyone younger than 6 months.

How should I take Maldemar (scopolamine)?

Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.

Take this medicine with a full glass of water.

You may take scopolamine with or without food.

If you take scopolamine to treat a Parkinson-like condition, you should not stop using this medicine suddenly. Stopping suddenly may make your condition worse.

Store at room temperature away from moisture and heat.

For the Consumer

Applies to scopolamine: transdermal patch extended release

Along with its needed effects, scopolamine (the active ingredient contained in Maldemar) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking scopolamine:

Incidence not known
  • Blurred vision
  • chest pain or discomfort
  • difficulty with urinating
  • dilation of the pupils
  • dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly
  • eye pain
  • flushing or redness of the skin
  • mood or mental changes
  • muscle weakness
  • nausea or vomiting
  • rash
  • redness of the white part of the eyes
  • restlessness
  • seeing, hearing, or feeling things that are not there
  • shortness of breath
  • slow or irregular heartbeat
  • sweating
  • unusual tiredness
  • unusually warm skin

Get emergency help immediately if any of the following symptoms of overdose occur while taking scopolamine:

Symptoms of overdose
  • Anxiety
  • blurred or loss of vision
  • change in consciousness
  • decrease in frequency of urination
  • decrease in urine volume
  • difficulty in passing urine (dribbling)
  • disturbed color perception
  • double vision
  • dry mouth
  • dry, flushed skin
  • fast, pounding, or irregular heartbeat or pulse
  • halos around lights
  • headache
  • hyperventilation
  • irritability
  • loss of consciousness
  • nervousness
  • night blindness
  • overbright appearance of lights
  • painful urination
  • pounding in the ears
  • seizures
  • shaking
  • sleepiness
  • trouble with sleeping
  • tunnel vision
  • unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness

Dialysis

Data not available

Scopolamine Breastfeeding Warnings

There are no data on the excretion of scopolamine into human milk. No adverse effects in nursing infants have been reported in association with scopolamine ingestion via breast milk. Scopolamine is considered compatible with breast-feeding by the American Academy of Pediatrics.

(web3)